Activin and Inhibin

IPN-60090 is an orally active and highly selective inhibitor of glutaminase 1 ( GLS1 : IC 50 =31 nM), with no activity observed against GLS-2. IPN-60090 exhibits excellent physicochemical and pharmacokinetic properties in vivo . IPN-60090 can be

IPN-60090 dihydrochloride is an orally active and highly selective inhibitor of glutaminase 1 ( GLS1 : IC 50 =31 nM), with no activity observed against GLS-2. IPN-60090 dihydrochloride exhibits excellent physicochemical and pharmacokinetic

IPN-60090 dihydrochloride is an orally active and highly selective inhibitor of glutaminase 1 ( GLS1 : IC 50 =31 nM), with no activity observed against GLS-2. IPN-60090 dihydrochloride exhibits excellent physicochemical and pharmacokinetic

IPN-60090 dihydrochloride is an orally active and highly selective inhibitor of glutaminase 1 ( GLS1 : IC 50 =31 nM), with no activity observed against GLS-2. IPN-60090 dihydrochloride exhibits excellent physicochemical and pharmacokinetic

IPN-60090 dihydrochloride is an orally active and highly selective inhibitor of glutaminase 1 ( GLS1 : IC 50 =31 nM), with no activity observed against GLS-2. IPN-60090 dihydrochloride exhibits excellent physicochemical and pharmacokinetic

IPN-60090 dihydrochloride is an orally active and highly selective inhibitor of glutaminase 1 ( GLS1 : IC 50 =31 nM), with no activity observed against GLS-2. IPN-60090 dihydrochloride exhibits excellent physicochemical and pharmacokinetic

IPR-803 is a potent inhibitor of the uPAR•uPA protein-protein interaction (PPI) . IPR-803 binds directly to uPAR with sub-micromolar affinity. IPR-803 displays anti-tumor activityIn VitroIPR-803 blocks invasion of breast cancer cells line

IPR-803 is a potent inhibitor of the uPAR•uPA protein-protein interaction (PPI) . IPR-803 binds directly to uPAR with sub-micromolar affinity. IPR-803 displays anti-tumor activityIn VitroIPR-803 blocks invasion of breast cancer cells line

IPR-803 is a potent inhibitor of the uPAR•uPA protein-protein interaction (PPI) . IPR-803 binds directly to uPAR with sub-micromolar affinity. IPR-803 displays anti-tumor activityIn VitroIPR-803 blocks invasion of breast cancer cells line

IPR-803 is a potent inhibitor of the uPAR•uPA protein-protein interaction (PPI) . IPR-803 binds directly to uPAR with sub-micromolar affinity. IPR-803 displays anti-tumor activityIn VitroIPR-803 blocks invasion of breast cancer cells line

IPR-803 is a potent inhibitor of the uPAR•uPA protein-protein interaction (PPI) . IPR-803 binds directly to uPAR with sub-micromolar affinity. IPR-803 displays anti-tumor activityIn VitroIPR-803 blocks invasion of breast cancer cells line

Estrogenic synthetic Daidzein derivative.